Chugai Pharma Europe has been bringing novel therapies to patients in Europe since 1993. Headquartered in London, we employ over 250 highly skilled experts, with offices in the UK, Germany and France. Our core therapy areas are oncology, immunology/rheumatology and haematology/haemophilia.
Chugai Pharma Europe is a wholly owned subsidiary of Chugai Pharmaceutical Co,. Ltd. one of Japan’s leading research-based pharmaceutical companies with a specialism in biopharmaceuticals, employing over 7,000 highly skilled experts. Chugai Pharmaceutical Co,. Ltd. was established in 1925.
Chugai has been a member of the Roche Group since 2002. Chugai has a 30-year history in biopharmaceuticals, focused on the creation of first and best-in-class products.